VentriPoint Diagnostics Ltd. VPTDF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.80K | 14.10K | 3.10K | 75.70K | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.80K | 14.10K | 3.10K | 75.70K | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 13.80K | 14.10K | 3.10K | 75.70K | 0.00 |
| SG&A Expenses | 304.70K | 311.20K | 469.30K | 472.90K | 787.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 371.50K | 379.40K | 532.90K | 544.70K | 844.50K |
| Operating Income | -357.70K | -365.30K | -529.80K | -469.00K | -844.50K |
| Income Before Tax | -480.90K | -491.10K | -180.70K | -546.00K | -931.40K |
| Income Tax Expenses | -- | -- | -37.40K | -- | -- |
| Earnings from Continuing Operations | -480.90K | -491.10K | -143.30K | -546.00K | -931.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -480.90K | -491.10K | -143.30K | -546.00K | -931.40K |
| EBIT | -357.70K | -365.30K | -529.80K | -469.00K | -844.50K |
| EBITDA | -- | -- | -529.50K | -468.70K | -844.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 186.75M | 186.75M | 168.01M | 167.28M | 159.73M |
| Average Diluted Shares Outstanding | 186.75M | 186.75M | 168.01M | 167.28M | 159.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |